InVivo Therapeutics Holdings Corp. (04I.F)

0.2545 0.0000 (0.00%) As of 09:21AM CEST. Market open.

InVivo Therapeutics Holdings Corp.

One Kendall Square
4th Floor Suite B14402 Building 1400 West
Cambridge, MA 02139
United States
617 863 5500
https://www.invivotherapeutics.com

Sector(s): 
Industry: 
Full-time employees: 6

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Richard M. Toselli M.D.	President, CEO, Chief Medical Officer & Director	768.38k	N/A	1958
Mr. Richard C. Christopher	CFO & Treasurer	500.78k	N/A	1970
Ms. Heather M. Hamel J.D.	Chief Legal Officer & General Counsel	416.18k	N/A	1990
Dr. Robert S. Langer Jr., Ph.D., ScD	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	1949
Dr. Joseph Philip Vacanti M.D.	Co-Founder	N/A	N/A	1949

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Corporate governance

InVivo Therapeutics Holdings Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.